Exclusive weekly insights for sharemarket success.
Tim Lincoln, Co-Founder and Chief Investment Officer, and Matt Swartz, Senior Portfolio Manager, will join the conversation once a month to share their passion and strategy for Lincoln Indicator’s Managed Funds, as well as their insights for investors.
In the final Taking Stock episode for 2025, Tim Lincoln and Kien Trinh reflect on a strong year for markets, from the small-cap rebound and shifting AI leadership to gold’s resurgence and active M&A. Under the microscope is radiopharmaceuticals group Telix Pharmaceuticals (TLX), a timely reminder of why Financial Health matters. They also tackle the question: What is the market outlook for 2026?
Experience Stock Doctor yourself by taking a FREE trial today.
To discuss the future of your investments in detail, book in a free consultation with a Lincoln representative.
To discuss the future of your investments in detail, book in a free consultation with a Lincoln financial expert.